N-[(2R,3S,4S,5S,6R)-2-[[(19E,21E,23Z,25Z,27E,29E,31E)-1,3,5,7,9,13,37-heptahydroxy-36-[4-(2-hydroxyethyl)piperazine-1-carbonyl]-17-[5-hydroxy-7-[4-(methylamino)phenyl]-7-oxoheptan-2-yl]-18-methyl-11,15-dioxo-16,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaen-33-yl]oxy]-3,5-dihydroxy-6-methyloxan-4-yl]-2-[4-(2-hydroxyethyl)piperazin-1-yl]acetamide

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 大环内酯类和类似物
• 英文名称: N-[(2R,3S,4S,5S,6R)-2-[[(19E,21E,23Z,25Z,27E,29E,31E)-1,3,5,7,9,13,37-heptahydroxy-36-[4-(2-hydroxyethyl)piperazine-1-carbonyl]-17-[5-hydroxy-7-[4-(methylamino)phenyl]-7-oxoheptan-2-yl]-18-methyl-11,15-dioxo-16,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaen-33-yl]oxy]-3,5-dihydroxy-6-methyloxan-4-yl]-2-[4-(2-hydroxyethyl)piperazin-1-yl]acetamide
• 化学式: C₇₃H₁₁₂N₆O₂₁
• 分子量: 1409.72
• InChiKey: LPKXBNVYYKGRAE-WWWWNCMVSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  100
• 可旋转键数：
  18
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.66
• 拓扑面积：
  402
• 氢给体数：
  14
• 氢受体数：
  25

反应信息

• 作为产物：
  描述：

  partricin A 在 叠氮磷酸二苯酯 、 三乙胺 作用下， 以 N,N-二甲基乙酰胺 为溶剂， 反应 10.0h， 生成 N-[(2R,3S,4S,5S,6R)-2-[[(19E,21E,23Z,25Z,27E,29E,31E)-1,3,5,7,9,13,37-heptahydroxy-36-[4-(2-hydroxyethyl)piperazine-1-carbonyl]-17-[5-hydroxy-7-[4-(methylamino)phenyl]-7-oxoheptan-2-yl]-18-methyl-11,15-dioxo-16,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaen-33-yl]oxy]-3,5-dihydroxy-6-methyloxan-4-yl]-2-[4-(2-hydroxyethyl)piperazin-1-yl]acetamide
  参考文献：
  名称：

  Amide derivatives of partricin A with potent antifungal activity

  摘要：

  A series of partricin A amides were synthesized using the active ester method by reaction with several amines on the carboxy group and then with some acids on the mycosamine group of partricin A. Most of the derivatives are more potent antifungals than the known reference standards, including amphotericin B, and a few are also less toxic and less hemolytic. Amides substituted with basic groups may give hydrosoluble salts, useful for injectable formulations, and two derivatives were selected for further development, namely, partricin A 2-dimethylaminoethyl amide (10, SPA-S-710) and N-dimethylaminoacetyl-partricin A 2-dimethylaminoethyl amide (22, SPA-S-752).

  DOI：

  10.1016/s0223-5234(97)86175-2